In 1942 I described the type of nasal hemorrhage associated with hypertension and arteriosclerosis,1 and it was asserted that this variety of nasal hemorrhage seemed to be a distinct clinical entity.
In 1949 cardiovascular epistaxis was again described.2 Its status as a distinct clinical entity was reasserted, and 28 cases were reviewed. In this latter article, the existence of a small group or plexus of blood vessels, lying at the junction of the nasal chamber and the nasopharynx, in the lateral wall, just beneath the inferior turbinate, was described. This group of vessels was given the name of the naso-nasopharyngeal plexus because of its location partly in the nose and partly in the nasopharynx. It was pointed out that this plexus was often the site of bleeding in cardiovascular epistaxis. In both of these articles a method of precision or spot packing was described which was found to
WOODRUFF GH. Severe Epistaxis: Recent Advances in Its Treatment. AMA Arch Otolaryngol. 1958;67(4):435–439. doi:10.1001/archotol.1958.00730010447010
Monkeypox Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.